as noted later in this issue ( see `` '' report of the who scientific group : primary immunodeficiency diseases '' '' ) , `` '' it may be considered as the treatment of choice for most immunodeficient patients requiring ig replacement . '' ''
C0021051
st immunodefici
C0021027
ng